Savvy Trades and Investments

[abh3vt]

Just sold the last of my HALO position in afterhours on Friday. Probably means its going to spike up on Monday! HALO was a perfect buy in the 30s, as it had lots of potential winners in its pipeline, but investors were worried then about its LT growth rate amid possible patent expirations and some of their potential blockbuster associations having some disappointing results. Its one of several reasons that biotech pharma can often sell at such low adjusted PEs relative to their growth rate.

HALO management did a great job with explaining its 5+ year vision, and that presentation was close to marking the bottom. That and they have executed really well in the last 2 earnings reports, with beat and raise quarters.

Its a great company and well managed IMHO, but HALO has hit my FV. If I were looking for undervalued biotech now, I'd recommend kicking the tires on HRMY, INDV, and AYTU. There's hair on all of them of course, but that's why they're cheap.